Stay updated with breaking news from Asensus Surgical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) had its price objective reduced by Cantor Fitzgerald from $1.50 to $1.30 in a report released on Friday morning, The Fly reports. Separately, HC Wainwright decreased their target price on shares of Asensus Surgical from $3.00 to $2.00 and set a buy rating on the stock in a report […]
Asensus Surgical (NYSEAMERICAN:ASXC – Get Rating) had its price objective trimmed by Cantor Fitzgerald from $1.50 to $1.30 in a research report report published on Friday, The Fly reports. Separately, HC Wainwright cut their price objective on Asensus Surgical from $3.00 to $2.00 and set a buy rating for the company in a research note […]
Three more public companies have updated their earnings. Here's the latest from Fathom Holdings, Asensus Surgical and VTv Therapeutics.
LOS ANGELES, Calif. (PRWEB) May 03, 2023 -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies,
RESEARCH TRIANGLE PARK, N.C., April 25, 2023 -- Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of... | April 25, 2023